Bain Capital Specialty Finance, Inc.
Business
Bain Capital Specialty Finance, Inc. is an externally managed, closed-end, non‑diversified management investment company that operates as a business development company focusing on middle‑market direct lending. It originates and invests primarily in senior secured loans (including unitranche loans), and opportunistically in mezzanine debt, subordinated securities, preferred and common equity, warrants and secondary purchases, and earns interest, fees and capital gains. Investment activity is managed by an SEC‑registered Advisor and Administrator leveraging Bain Capital Credit resources, with decisions subject to a Credit Committee and Board oversight. The Company targets middle‑market companies across North America, Europe and Australia and distributes its securities and dividends through public offerings, securitizations, credit facilities and a dividend reinvestment plan.
Summary from filing dated 2025-02-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Dividend income | 22 | 29 | 36 | 23 | — | |
| Total investment income | 273 | 293 | 298 | 220 | 197 | |
| Interest and debt financing expenses | 81 | 75 | 80 | 52 | 51 | |
| Base management fee | 37 | 36 | 36 | 35 | 35 | |
| Incentive fee | 18 | 29 | 25 | 20 | 24 | |
| Professional fees | 3 | 3 | 3 | 3 | 3 | |
| Directors fees | 720,000 | 695,000 | 716,000 | 707,000 | 725,000 | |
| Other general and administrative expenses | 8 | 10 | 8 | 6 | 5 | |
| Total expenses, net of fee waivers | 148 | 154 | 153 | 116 | 110 | |
| Net investment income before taxes | 125 | 139 | 145 | 104 | 88 | |
| Income tax expense, including excise tax | 4 | 4 | 3 | 837,000 | 134,000 | |
| Net investment income | 122 | 135 | 142 | 103 | 88 | |
| Net realized gain (loss) | −28 | −10 | −44 | −3 | 21 | |
| Net realized gain (loss) on foreign currency transactions | 761,000 | −320,000 | −5 | 5 | −3 | |
| Net realized gain (loss) on forward currency exchange contracts | −6 | 2 | −407,000 | 21 | −24 | |
| Net change in unrealized appreciation on foreign currency translation | 1 | −251,000 | 4 | −4 | −936,000 | |
| Net change in unrealized appreciation on forward currency exchange contracts | −13 | 6 | −2 | −5 | 28 | |
| Net change in unrealized appreciation on investments | 22 | −12 | 29 | −11 | 16 | |
| Total net gain (loss) | −23 | −15 | −18 | 3 | 32 | |
| Net increase in net assets resulting from operations | 99 | 119 | 123 | 105 | 120 | |
| Basic and diluted net investment income per share of common stock | 1.88 | 2.09 | 2.19 | 1.59 | 1.36 | |
| Basic increase in net assets resulting from operations per share of common stock | 1.53 | 1.85 | 1.91 | 1.63 | 1.86 | |
| Diluted increase in net assets resulting from operations per share of common stock | 1.53 | 1.85 | 1.91 | 1.63 | 1.86 | |
| Basic weighted average common stock outstanding | 65 | 65 | 65 | 65 | 65 | |
| Diluted weighted average common stock outstanding | 65 | 65 | 65 | 65 | 65 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2025 2025-09-30 | FY 2025 2025-06-30 | FY 2025 2025-03-31 | FY 2024 2024-12-31 |
|---|---|---|---|---|---|---|
| Investments at fair value | 2,508 | — | — | — | 2,431 | |
| Cash and cash equivalents | 23 | — | — | — | 52 | |
| Foreign cash (cost of $2,477 and $2,640, respectively) | 3 | — | — | — | 2 | |
| Restricted cash and cash equivalents | 33 | — | — | — | 46 | |
| Collateral on derivatives | 11 | — | — | — | 10 | |
| Deferred financing costs | 4 | — | — | — | 5 | |
| Interest receivable on investments | 38 | — | — | — | 39 | |
| Interest rate swap | 8 | — | — | — | 0 | |
| Receivable for sales and paydowns of investments | 29 | — | — | — | 38 | |
| Prepaid insurance | 489,000 | — | — | — | 197,000 | |
| Unrealized appreciation on forward currency exchange contracts | 0 | — | — | — | 5 | |
| Dividend receivable | 5 | — | — | — | 6 | |
| Total Assets | 2,663 | — | — | — | 2,632 | |
| Debt (net of unamortized debt issuance costs of $10,110 and $4,929, respectively) | 1,471 | — | — | — | 1,390 | |
| Interest payable | 12 | — | — | — | 14 | |
| Payable for investments purchased | 2 | — | — | — | 29 | |
| Collateral payable on derivatives | 13 | — | — | — | 0 | |
| Unrealized depreciation on forward currency exchange contracts | 9 | — | — | — | 1 | |
| Base management fee payable | 9 | — | — | — | 9 | |
| Incentive fee payable | 6 | — | — | — | 5 | |
| Accounts payable and accrued expenses | 13 | — | — | — | 15 | |
| Distributions payable | 10 | — | — | — | 29 | |
| Total liabilities | 1,545 | — | — | — | 1,492 | |
| Commitments and Contingencies (See Note 11) | — | — | — | — | — | |
| Common stock, par value $0.001 per share, 100,000,000,000 and 100,000,000,000 shares authorized, 64,868,507 and 64,562,265 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively | 65,000 | — | — | — | 65,000 | |
| Paid in capital in excess of par value | 1,161 | — | — | — | 1,159 | |
| Total distributable loss | −44 | — | — | — | −20 | |
| Total Net Assets | 1,117 | — | — | — | 1,140 | |
| Total Liabilities and Total Net Assets | 2,663 | — | — | — | 2,632 | |
| Net asset value per share | 17.23 | 17.4 | 17.56 | 17.64 | 17.65 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Net increase in net assets resulting from operations | 99 | 119 | 123 | 105 | 120 | |
| Purchases of investments | −1,308 | −1,626 | −844 | −1,404 | −1,177 | |
| Proceeds from principal payments and sales of investments | 1,245 | 1,486 | 938 | 988 | 1,399 | |
| Net change in unrealized appreciation on foreign currency translation | −1 | 251,000 | −4 | 4 | 936,000 | |
| Increase in investments due to PIK | −34 | −26 | −23 | −15 | −11 | |
| Accretion of discounts and amortization of premiums | −5 | −5 | −5 | −5 | −6 | |
| Amortization of deferred financing costs and debt issuance costs | 5 | 4 | 4 | 4 | 6 | |
| Collateral on derivatives | −1 | −2 | 2 | −7 | 2 | |
| Interest receivable on investments | 1 | −2 | −3 | −15 | −4 | |
| Interest rate swap | −70,000 | 0 | 0 | — | — | |
| Prepaid insurance | −292,000 | 13,000 | −16,000 | −1,000 | −193,000 | |
| Dividend receivable | 391,000 | 4 | 4 | 5 | −11 | |
| Interest payable | −1 | 577,000 | 1 | 5 | −1 | |
| Collateral payable on derivatives | 13 | 0 | 0 | — | — | |
| Base management fee payable | 248,000 | 231,000 | 23,000 | 114,000 | 3 | |
| Incentive fee payable | 1 | −3 | −2 | 4 | 928,000 | |
| Accounts payable and accrued expenses | −2 | 5 | 7 | −943,000 | 636,000 | |
| Net cash provided by (used in) operating activities | 30 | −27 | 219 | −317 | 266 | |
| Borrowings on debt | 1,306 | 867 | 348 | 793 | 1,425 | |
| Repayments on debt | −1,228 | −735 | −480 | −462 | −1,462 | |
| Payments of financing costs | −9 | −3 | 0 | −4 | — | |
| Proceeds from issuances of common stock (net of offering and underwriting costs) | 5 | 0 | 0 | — | — | |
| Purchase of common shares issued in connection with dividend reinvestment plan | 924,000 | 0 | 0 | — | — | |
| Stockholder distributions paid | −146 | −114 | −99 | −88 | −88 | |
| Net cash provided by (used in) financing activities | −72 | 14 | −231 | 238 | −139 | |
| Net decrease in cash, foreign cash, restricted cash and cash equivalents | −42 | −13 | −12 | −79 | 127 | |
| Effect of foreign currency exchange rates | 2 | −571,000 | −1 | 649,000 | −5 | |
| Cash interest paid during the period | 77 | 70 | 75 | 43 | 47 | |
| Cash paid for excise taxes during the period | 3 | 2 | 834,000 | 134,000 | 237,000 | |
| Cash paid for state income taxes during the period | 0 | 163,000 | 382,000 | 0 | — |